<?xml version="1.0" encoding="UTF-8"?>
<p id="par0150">APAP treatment caused a marked decrease in the GSH
 <sub>t</sub>/GSSG ratio (13.24 ± 2.37, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>f and Supplementary data 1, 
 <italic>P</italic> &lt; 0.01). In APAP-treated mice, administration with silymarin (74.92 ± 13.60) or 1400 mg/kg/day GMSYS (71.67 ± 8.48) significantly increased the GSH
 <sub>t</sub>/GSSG ratio compared to that in the APAP group (
 <italic>P</italic> &lt; 0.05). Treatment with 700 mg/kg/day GMSYS increased the GSH
 <sub>t</sub>/GSSG ratio (39.87 ± 12.87) but not significantly, compared to that in the APAP group. Treatment with silymarin alone or 1400 mg/kg/day GMSYS alone showed no significant changes in the GSH
 <sub>t</sub>/GSSG ratio compared to that in the control group.
</p>
